Anticardiolipin Antibodies Are Elevated in Drug-free, Multiply Affected Families with Schizophrenia

Overview

Journal J Clin Immunol

Publisher Springer

Specialty Allergy & Immunology

Date 1994 Jan 1

PMID 8132739

Citations 6

Authors

M Firer

P Sirota

K Schild

A Elizur

H Slor

Affiliations

Soon will be listed here.

Abstract

The objective of this study was to measure anticardiolipin antibodies in patients and healthy relatives in multicase families with schizophrenia. Twenty-eight (28) multicase families with schizophrenia were examined. One hundred three drug-free patients and 66 first-degree relatives consented to evaluation by DSM-III-R criteria. Criteria for patient definition included the following: age > or = 16, a confirmed hospital diagnosis of schizophrenia, knowledge of biological parents, and consent to participate. Additional data were drawn from family history and medical records. Serum samples were tested separately for IgG and IgM anticardiolipin by enzyme-linked immunosorbent assay (ELISA) and designated positive/negative by comparison to the reactivity of an age-matched control group. IgG anticardiolipin antibodies were significantly more common in both patients and relatives compared to controls. IgM anticardiolipin antibodies were significantly more common in patients. In 75% of families at least one member was anticardiolipin positive and this positivity correlated with patient positivity. The relevance of anticardiolipin antibodies in both patients and healthy relatives of some multicase families to the pathogenesis of schizophrenia is discussed.

Citing Articles

High Prevalence of aCL-IgA and aβ2GPI-IgA in Drug-Free Schizophrenia Patients: Evidence of a Potential Autoimmune Link.

Samoud S, Zamali I, Korbi F, Mtiraoui A, Ben Hmid A, Hannachi N Antibodies (Basel). 2024; 13(4).

PMID: 39584992 PMC: 11587061. DOI: 10.3390/antib13040092.

Anti-phospholipid syndrome associated with schizophrenia description of five patients and review of the literature.

Regina P, Pnina R, Natur A, Yair L Immunol Res. 2017; 65(2):438-446.

PMID: 28102512 DOI: 10.1007/s12026-017-8895-1.

Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management.

Jonsson A, Spigset O, Hagg S CNS Drugs. 2012; 26(8):649-62.

PMID: 22731933 DOI: 10.2165/11633920-000000000-00000.

Antipsychotic-induced venous thromboembolism: a review of the evidence.

Hagg S, Spigset O CNS Drugs. 2002; 16(11):765-76.

PMID: 12383032 DOI: 10.2165/00023210-200216110-00005.

The presence of lupus anticoagulant and anticardiolipin antibodies in patients undergoing long-term neuroleptic treatment.

Schwartz M, Rochas M, Toubi E, Sharf B J Psychiatry Neurosci. 1999; 24(4):351-2.

PMID: 10516804 PMC: 1189039.

References

Zarrabi M, Zucker S, Miller F, Derman R, Romano G, Hartnett J . Immunologic and coagulation disorders in chlorpromazine-treated patients. Ann Intern Med. 1979; 91(2):194-9. DOI: 10.7326/0003-4819-91-2-194. View

Harris E . Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group. Am J Clin Pathol. 1990; 94(4):476-84. DOI: 10.1093/ajcp/94.4.476. View

McNeil H, Hunt J, Krilis S . New aspects of anticardiolipin antibodies. Clin Exp Rheumatol. 1990; 8(6):525-7. View

Galli M, Comfurius P, Maassen C, Hemker H, De Baets M, Barbui T . Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 1990; 335(8705):1544-7. DOI: 10.1016/0140-6736(90)91374-j. View

Sammaritano L, Gharavi A, Lockshin M . Antiphospholipid antibody syndrome: immunologic and clinical aspects. Semin Arthritis Rheum. 1990; 20(2):81-96. DOI: 10.1016/0049-0172(90)90021-7. View

Sirota P, Firer M, Schild K, Tanay A, Elizur A, Meytes D . Autoantibodies to DNA in multicase families with schizophrenia. Biol Psychiatry. 1993; 33(6):450-5. DOI: 10.1016/0006-3223(93)90173-b. View

Harris E, Pierangeli S, Barquinero J, Ordi-Ros J . Anticardiolipin antibodies and binding of anionic phospholipids and serum protein. Lancet. 1990; 336(8713):505-6. DOI: 10.1016/0140-6736(90)92053-k. View

Manoussakis M, Tzioufas A, Silis M, Pange P, Goudevenos J, Moutsopoulos H . High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol. 1987; 69(3):557-65. PMC: 1542366. View

Asherson R . Antiphospholipid antibodies and "syndromes": many questions and few answers. Isr J Med Sci. 1990; 26(5):284-6. View

10.

Manoussakis M, Gharavi A, Drosos A, Kitridou R, Moutsopoulos H . Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immunopathol. 1987; 44(3):297-307. DOI: 10.1016/0090-1229(87)90073-0. View

11.

Alarcon-Segovia D . Pathogenetic potential of antiphospholipid antibodies. J Rheumatol. 1988; 15(6):890-3. View

12.

Sirota P . Is schizophrenia an autoimmune disease?. Isr J Med Sci. 1990; 26(12):694-7. View

13.

Tomer Y, Buskila D, Shoenfeld Y . Pathogenic significance and diagnostic value of lupus autoantibodies. Int Arch Allergy Immunol. 1993; 100(4):293-306. DOI: 10.1159/000236429. View

14.

Canoso R, de Oliveira R, Nixon R . Neuroleptic-associated autoantibodies. A prevalence study. Biol Psychiatry. 1990; 27(8):863-70. DOI: 10.1016/0006-3223(90)90467-g. View

15.

Yannitsi S, Manoussakis M, Mavridis A, Tzioufas A, Loukas S, Plataris G . Factors related to the presence of autoantibodies in patients with chronic mental disorders. Biol Psychiatry. 1990; 27(7):747-56. DOI: 10.1016/0006-3223(90)90590-x. View

16.

Endicott J, Spitzer R . A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry. 1978; 35(7):837-44. DOI: 10.1001/archpsyc.1978.01770310043002. View

17.

McNeil H, Hunt J, Krilis S . Antiphospholipid antibodies--new insights into their specificity and clinical importance. Scand J Immunol. 1992; 36(5):647-52. DOI: 10.1111/j.1365-3083.1992.tb03124.x. View

18.

Chengappa K, Carpenter A, Keshavan M, Yang Z, Kelly R, Rabin B . Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients. Biol Psychiatry. 1991; 30(7):731-5. DOI: 10.1016/0006-3223(91)90019-i. View

19.

McNeil H, Simpson R, Chesterman C, Krilis S . Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A. 1990; 87(11):4120-4. PMC: 54059. DOI: 10.1073/pnas.87.11.4120. View

20.

Firer M, Spivak T, Shoenfeld Y, Slor H . The effects of incubation temperature and coating procedure on the measurement of antibodies to cardiolipin. J Immunol Methods. 1991; 143(1):31-9. DOI: 10.1016/0022-1759(91)90269-l. View